Summary of this blog
- B2B HealthTech marketing sells to a committee. A hospital, health system or payer decision involves clinical, IT, security, procurement and finance, each reading different evidence, and most of that reading happens before anyone from the vendor is invited in. The job is to be present, in writing, for every seat at that table.
- The buyer arrives late and decided. 6sense’s 2025 report found buyers contact a vendor 61% of the way through the journey and that the first vendor contacted wins eight deals in ten. Gartner reports 75% of B2B buyers prefer a rep-free experience. TrustRadius found 78% already knew the products they bought before the purchase began.
- Eight moves generate enterprise pipeline: map the buying committee, build the evidence page the clinician reads first, answer procurement in public, run search against the buyer’s own questions, turn customers into references, move the owned pipeline with email, run account programmes for the top fifty, and measure pipeline, cost and cycle.
- The moves are built in order. The committee map and the evidence page come first because every later move sends the buyer to them. Paid media and events wait until there is a page worth sending a buyer to.
- Judge the programme on qualified pipeline, cost per opportunity and sales cycle length, reported monthly, with the founder’s own introductions on a separate line.
B2B HealthTech marketing sells to a committee that meets without you. A hospital buying a clinical platform, a health system buying an integration layer or a payer buying an analytics tool involves a clinical lead, a CIO or IT director, a security officer, procurement and finance, and each reads different evidence at a different moment. Most of the reading happens before anyone from the vendor is invited in. The marketing job is to be in that room in writing, for every seat, before the shortlist forms.
The evidence that the buyer arrives late and decided is consistent. 6sense’s 2025 Buyer Experience Report, drawn from nearly 4,000 B2B buyers, found that buyers first contact a seller 61% of the way through their journey and that the vendor contacted first wins eight deals in ten. Gartner reports 75% of B2B buyers prefer a rep-free experience. TrustRadius’s 2024 B2B Buying Disconnect, from 2,164 buyers, found 78% already knew the products they bought before the purchase began, rising to 86% in enterprise.
This B2B HealthTech marketing guide sets out eight moves for the founder, CEO or head of marketing at a HealthTech, health SaaS or MedTech company selling to hospitals, health systems, payers and large provider groups, in the US, the UK or Europe. Our companion on B2B health marketing SEO covers the search slice in depth, and our pillar on the HealthTech marketing agency model covers who builds the programme.
Enterprise health buyers decide in committee, on evidence, before the vendor is in the room. B2B HealthTech marketing is the work of being in that room anyway.
Why the enterprise health buyer is different
Three things separate a hospital committee from the buying group most B2B HealthTech marketing playbooks assume. The clinical seat reads outcomes and peer evidence before it reads benefits. The security and IT seats have a questionnaire that decides whether the deal proceeds at all. And every claim the vendor makes is bounded by the product’s regulatory status. McKinsey’s 2024 B2B Pulse found buyers using an average of ten channels and splitting a third each between in-person, remote and self-serve. In health, the self-serve third is where the committee does most of its reading.
1. Map the buying committee before the first page
The first move in B2B HealthTech marketing is a map of who decides, in what order, on what evidence. For a clinical platform sold to a health system, the map usually runs: a clinical champion who feels the problem, a service line director who owns the budget, a CIO who owns the integration, a security officer who owns the risk, procurement that owns the contract, and finance that owns the return. Each seat has a question the marketing has to answer in writing, because the seat will read before it will meet.
How B2B HealthTech marketing teams build the map
Take the last five deals won and the last five lost, which is the raw material of B2B HealthTech marketing. For each, list every person who touched the decision, the question they asked, the evidence that satisfied them and the month they entered. The pattern that emerges is the map. At Healthora, we have seen that companies which build this map from real deals usually find that one seat, often security or finance, entered later than expected and stalled the deal, and that the content plan had nothing written for that seat at all.
What the map changes downstream
Every later move in this guide is written against the map. The evidence page is for the clinical seat, and the security and integration pages are for the CIO and the security officer. Procurement and finance get the pricing and contract pages. Then the account programme names the seats at each target account. Our guide to HealthTech demand generation shows how the map becomes a quarterly plan.
2. Build the evidence page the clinician reads first
The second move is the page the clinical seat reads before it will take a call. Outcomes from a site like theirs, the study or the audit behind the outcomes, the population, the comparator and the limitations, written by someone who can be named. B2B HealthTech marketing without an evidence page is asking a clinician to take a benefit claim on trust, and the clinician has been trained for a decade to do the opposite.
What the B2B HealthTech marketing evidence page contains
The B2B HealthTech marketing evidence page contains the numbers the product can support, the method behind them and the regulator’s view of what may be claimed. Adjectives stay out. In the US, the FTC’s Health Products Compliance Guidance requires “competent and reliable scientific evidence” for health claims in advertising, and a device’s claims are bounded by its FDA classification. A claim on the evidence page that the regulatory team has not read is a liability, and a clinician will spot it before the regulator does.
Why the evidence page ranks as well as it converts
Google’s guidance on helpful content says its systems weight experience, expertise, authority and trust more heavily on topics that affect health. An evidence page with a named clinical author, a method and a reference list is what that guidance describes. A B2B HealthTech marketing team that builds the page for the clinician tends to find it also becomes the page that ranks for the buyer’s most serious searches.
3. Answer procurement in public
The third move is to publish what the security, IT, procurement and finance seats will ask anyway. HIPAA and GDPR posture, hosting, data residency, the integration standards supported, uptime, the security certifications held, the contract terms, and the pricing model. TrustRadius found 51% of enterprise buyers want transparent pricing and 44% stop engaging when a vendor pushes for contact too early. B2B HealthTech marketing that hides these answers behind a form is asking the committee to shortlist a vendor it cannot evaluate.
The B2B HealthTech marketing pages procurement reads
Four B2B HealthTech marketing pages do the work. A security and compliance page with the certifications, the sub-processors and the questionnaire available on request. An integrations page naming the record systems and standards supported, with what “supported” means. A pricing page that explains the model and the drivers even where it cannot print a figure. A contract and implementation page that says how long onboarding takes and who does what. Our guide to the HealthTech landing page covers how these pages are built to convert.
Why public answers shorten the cycle
A committee that can answer its own security and pricing questions from the website enters the sales conversation further along, with fewer seats still to convince. At Healthora, we have seen that companies which publish a proper security page and a pricing model page tend to see procurement questionnaires arrive earlier in the cycle and the cycle shorten, because the seats that used to stall the deal have already read what they needed.
4. Run search against the buyer’s own questions
The fourth move is search, built from the questions each seat types rather than the words the vendor uses. The clinical seat searches for the condition, the pathway and the outcome. A CIO searches for the integration standard and the record system by name, and procurement searches for the vendor plus “security”, “pricing” and “reviews”. B2B HealthTech marketing that ranks for the product category and nothing else is present for one search in ten.
The three B2B HealthTech marketing search programmes
First in B2B HealthTech marketing search, the evidence and pathway content the clinical seat reads, written by named clinical authors. Second, the integration and security pages the technical seats read, one per standard and record system. Third, the brand searches every seat runs before a shortlist, where the vendor’s own pages, reviews and comparisons have to answer well. Our companion on B2B health marketing SEO covers the keyword work in detail.
Why search is the cheapest seat at the table
A page written once for the security officer answers every security officer who searches for it, for years. That is why search comes before paid media in B2B HealthTech marketing: the evidence, integration and security pages are the pages a paid campaign would send the buyer to anyway, and they have to exist first. Gartner’s 2025 CMO Spend Survey found paid media taking 30.6% of budgets while 59% of CMOs say the budget cannot deliver the strategy, which is often the cost of buying traffic to pages that do not yet answer the committee.
A specialist’s view on your enterprise pipeline
Not sure which seats on the committee your marketing is missing?
Book a free consultation with Healthora. We’ll map your buying committee with you from your last ten deals, tell you candidly which seats have nothing written for them, and share practical recommendations you can act on straight away, whether you decide to work with us or not.
Book a Free Consultation5. Turn customers into references and referrals
The fifth move is the one the cautious majority buys on. TrustRadius found that buyers’ own prior experience with a product was used by 52% and rated influential by 71%, and that 66% prefer established products. A health system CIO wants to speak to a CIO at a similar system before she signs. B2B HealthTech marketing builds the reference programme as a product: named customers, written case studies with outcomes, a reference call the sales team can book, and a referral ask in the customer success process.
Building the B2B HealthTech marketing reference programme
Start the B2B HealthTech marketing reference programme with the three best customers and ask for three things: a case study with a number, a quote from the clinical lead and the CIO, and permission to take a reference call a quarter. Write the case study around the committee map, so each seat finds its own evidence in it. Then add a referral step to the ninety-day review with every customer, because a happy clinical lead knows three peers with the same problem and will introduce the vendor if asked.
What a reference is worth at the shortlist stage
TrustRadius found 63% of buyers shortlist two or three vendors and 96% shortlist five or fewer. At that stage the committee is choosing between names it already trusts, and the deciding evidence is usually a conversation with a peer. A B2B HealthTech marketing programme with five reference customers by role and setting wins those conversations; a programme with none is asking the sales team to win them on charm. Our case studies show the form.
6. Move the pipeline you already own with email
The sixth move is email to the contacts the company already has: the champions who went quiet, the evaluations that stalled at security, the conference list from last year, the customers who could refer. Enterprise health cycles are long and a committee that paused in March may restart in September when the budget year turns. B2B HealthTech marketing that treats email as a newsletter misses the most valuable use, which is putting the right evidence in front of a seat that has gone quiet.
B2B HealthTech marketing email, written for the seat
A security officer who stalled gets the new certification and the updated questionnaire. The clinical champion who went quiet gets the new outcomes study, and the CIO gets the new integration. Each email is short, names the evidence, links to the page and asks for nothing more than a reply. Our guide to healthcare email marketing covers sequencing and compliance, including the consent rules that apply to clinical contacts in the UK and Europe.
The pipeline review email produces
Email is the cheapest source of qualified pipeline in B2B HealthTech marketing, because the contacts already know the product and the seats have already asked their questions. At Healthora, we have seen that a quarterly evidence email to stalled evaluations, written for the seat that stalled, tends to reopen a meaningful share of them, and that those reopened deals close faster than new ones because the committee has already done most of its reading.
7. Run account programmes for the top fifty
The seventh move is an account programme for the fifty organisations the company most wants to win. For each, the committee map is filled in with names, the evidence each seat needs is prepared, the reference customer most like them is identified, and the sales and marketing teams agree who contacts whom and when. B2B HealthTech marketing at enterprise scale is a numbered list of accounts and a plan per account, run alongside the search and reference programmes that serve everyone else.
Choosing the fifty accounts for B2B HealthTech marketing
Choose the fifty for B2B HealthTech marketing from the pattern in the deals won: the size, the record system, the specialty mix, the region and the trigger that started the search. Then check each account for a trigger in the last two quarters: a new CIO, a merger, an incident, a published strategy, a regulatory deadline. Accounts with a trigger go first. Our guide to healthcare account-based marketing covers the mechanics.
What the account plan contains
The named seats, the evidence for each, the reference customer, the trigger, the first contact and the owner. One page per account, reviewed monthly. A B2B HealthTech marketing team that runs fifty of these pages has a pipeline it can forecast by account, which is the forecast the board wants and the one a search programme alone cannot give.
8. Measure pipeline, cost and cycle
The eighth move is the report. Qualified pipeline by source, cost per opportunity, and sales cycle length by stage, on one page, monthly, with the founder’s own introductions on their own line. B2B HealthTech marketing that reports traffic and leads is reporting activity; the committee does not care about traffic, and neither does the board. The definitions are agreed with sales before the first count, because “qualified” in an enterprise health deal means a named committee, a stated problem and a budget year.
The three B2B HealthTech marketing numbers and their definitions
Three B2B HealthTech marketing numbers. Qualified pipeline: opportunities with a named committee, a stated problem and a timeframe, valued at the expected contract. Cost per opportunity: the marketing spend in the period divided by those opportunities, by source. Cycle length: days from first qualified contact to close, by stage, so the stall at security or procurement is visible. Rock Health recorded $6.4 billion of US digital health funding across 245 deals in the first half of 2025, and the investors behind those deals will ask for these three numbers by name.
What the report changes
A report by source shows which of the eight moves is producing and which is decorative. The cycle by stage shows which seat is stalling deals and therefore which page to write next. So a B2B HealthTech marketing programme reviewed against this page every month gets better every quarter, because the page tells the team where the next piece of evidence belongs. Our guide to the HealthTech marketing audit shows the same page from the reviewer’s side.
B2B HealthTech marketing in practice: the first two quarters
A B2B HealthTech marketing programme that builds the eight moves runs across two quarters. Quarter one is the foundation: the committee map from the last ten deals, the evidence page with a named clinical author, the security, integration and pricing pages, and the first three reference customers. Quarter two is the reach: the search programme against each seat’s questions, the quarterly evidence email to stalled evaluations, the first twenty account plans, and the one-page report with its definitions agreed.
Companies whose B2B HealthTech marketing is built in this order usually notice the change first in the sales conversation. Committees arrive having read the evidence page and the security page, the first call starts from their problem rather than the product, and procurement questionnaires arrive earlier. Then the report begins to show pipeline from search, references and email on their own lines, the founder’s line stops being the largest, and the cycle by stage shows the stall at security shrinking.
The recap below lists the eight B2B HealthTech marketing moves in the order to build them.
- Map the buying committee before the first page. Six seats, six questions, from the last ten deals. Every later move is written against the map.
- Build the evidence page the clinician reads first. Outcomes, method, comparator, limitations, a named author, and claims the regulator allows.
- Answer procurement in public. The B2B HealthTech marketing pages for security, integrations, pricing model and implementation, published so the committee can evaluate before it calls.
- Run search against the buyer’s own questions. Three programmes: clinical evidence, technical standards and brand searches, before any paid media.
- Turn customers into references and referrals. Case studies by seat, a reference call a quarter, a referral ask at every ninety-day review.
- Move the pipeline you already own with email. Evidence for the seat that stalled, sent quarterly to every paused evaluation.
- Run account programmes for the top fifty. B2B HealthTech marketing by name: one page per account, seats, evidence, reference, trigger, owner. Accounts with a trigger go first.
- Measure pipeline, cost and cycle. One page a month, by source and by stage, with the founder’s introductions on their own line. The core of B2B HealthTech marketing reporting.
The eight moves can be built by an in-house team, by a specialist agency, or by the hybrid most health companies end up running, with a marketing lead in the building and specialists outside it. Our guide to HealthTech agency vs in-house compares the options, and our services page shows how Healthora runs the programme for companies selling into health systems.
A specialist in health understands that the committee reads before it meets, that the clinical seat reads evidence before benefits, and that a claim the regulator has not seen is a risk rather than a message. Build the map and the evidence page first, publish what procurement will ask anyway, and report the three numbers monthly. B2B HealthTech marketing done in that order produces enterprise pipeline the board can forecast.
Ready to find out which seats your marketing is missing?
HEALTHORA SPECIALISES IN HEALTH
Book a free consultation with Healthora. We’ll review your committee map, your evidence and your procurement pages with you, identify the growth opportunities, and share practical recommendations you can apply immediately, whether you decide to work with us or not.
Book a Free ConsultationFrequently asked questions
What is B2B HealthTech marketing?
B2B HealthTech marketing is the work of generating qualified pipeline for a health technology company that sells to organisations: hospitals, health systems, payers, provider groups and life sciences companies. The buyer is a committee of clinical, technical, security, procurement and finance roles, and most of its decision is made from written evidence before the vendor is invited in, so the discipline centres on evidence pages, public procurement answers, search, references, email and account programmes.
How is marketing to hospitals different from other B2B marketing?
Three ways. The clinical seat on the committee reads outcomes and peer evidence before it reads benefits. The security and IT seats run a questionnaire that decides whether the deal proceeds at all. And every claim is bounded by the product’s regulatory status, so the FTC, the FDA and their UK and European equivalents shape what B2B HealthTech marketing can say. Cycles are also longer, usually two or more quarters, because committees meet on their own schedule.
Which channel generates the most enterprise pipeline in HealthTech?
References and referrals usually produce the highest-quality pipeline, search produces the most consistent volume once the evidence and technical pages exist, and email to stalled evaluations produces the cheapest. Paid media and events work once there is a page worth sending a buyer to. Most B2B HealthTech marketing programmes run search, references and email to depth before adding a fourth channel.
Should a HealthTech company publish its pricing?
Publish the model, the drivers and a range wherever the contract structure allows it, even if the exact figure depends on scope. TrustRadius found 51% of enterprise buyers want transparent pricing and 44% stop engaging when a vendor pushes for contact too early. A pricing page that explains how the price is built lets procurement and finance evaluate before they call, which is the point of B2B HealthTech marketing to a committee.
How long does it take to generate enterprise pipeline?
The first qualified opportunities from a rebuilt B2B HealthTech marketing programme usually appear in the second or third month, from email and references. Search takes two to three quarters to produce consistent volume. A repeatable pipeline number, with cost per opportunity holding across two quarters, takes six months, because hospital and payer committees move on their own schedule.
How much should a HealthTech company spend on B2B marketing?
B2B HealthTech marketing spend depends on the stage, the contract value and the number of target accounts, and is better sized from the pipeline number the board expects than from a percentage of revenue. Gartner’s 2025 survey found budgets flat at 7.7% of revenue with 59% of CMOs saying that is insufficient for their strategy. Book a consultation for a view on the right structure for your stage.
Do we need account-based marketing or search first?
The evidence page, the procurement pages and search come first in B2B HealthTech marketing, because every account programme sends the committee to those pages. Account programmes for the top fifty come in the second quarter, once the pages exist and the first references are in place. Running account outreach before the pages are ready sends a named CIO to a website that cannot answer her questions.
Keep reading
More on generating enterprise pipeline in health: